Welcome to the e-CCO Library!

P449 Systematic review with meta-analysis: risk of lymphoma associated with anti-tumour necrosis factor (TNF) agents in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. CHUPIN1, V. Perduca2, C. Bellanger1, F. Carbonnel1, C. Dong1

Created: Thursday, 30 January 2020, 10:12 AM
P449: Autologous fat graft injection for the treatment of perianal fistulas in Crohn’s disease: A systematic review and single-arm meta-analysis
Year: 2022
Source: ECCO'22
Authors: De Gregorio, M.(1,2);Tiang, T.(3);Lee, T.(1);Stellingwerf, M.E.(4);Basnayake, C.(1,2);Kamm, M.A.(1,2);Niewiadomski, O.(1,5);Schulberg, J.D.(1,2);Wright, E.K.(1,2);Connell, W.(1);Thompson, A.J.(1,2);D'Souza co-lead senior author, B.(3,6);Ding, N.S.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P449: Cost Effectiveness of a Proactive Therapeutic Drug Monitoring Strategy in Patients with Inflammatory Bowel Disease Receiving Infliximab
Year: 2021
Source: ECCO'21 Virtual
Authors: Doherty, J.(1);Varley, R.(1);Healy, M.(2);Dunne, C.(1);Mac Carthy, F.(1);Mc Kiernan, S.(1);Hartery, K.(1);Kevans, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P449: Double assessment of ileal pouch-anal anastomosis before ileostomy reversal
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Gklavas1*, G. Exarchos1, L. Metaxa2, G. Karamanolis1, I. Papaconstantinou1

Created: Thursday, 21 February 2019, 9:14 AM
P449: Efficacy and safety of switching between originator and biosimilar infliximab in patients with inflammatory bowel disease in practical clinic: results to 6 months
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Díaz Hernández*1, G. E. Rodríguez González1, M. Vela González1, C. A. Tardillo Marín1, C. Y. Rodríguez Díaz1, L. Arranz Hernández1, J. A. Montero Delgado2, M. San Juan Acosta1, F. Pérez Hernández1

Created: Friday, 22 February 2019, 9:49 AM
P449: Minimally invasive IPAA in UC: Preliminary results from a referral center
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fortuna, L.(1)*;Bottari, A.(1);Ficari, F.(1);Cricchio, M.(1);Cianchi, F.(1);Scaringi, S.(1);
Created: Friday, 14 July 2023, 11:05 AM
P449: Patient support program for adalimumab-treated patients with Crohn's disease in Brazil: impact on patients' adherence and persistence
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Teich V.*1, Arinelli R.1, Gulart A.1, Chaves L.2, Garg V.2, Skup M.2

Created: Wednesday, 20 February 2019, 10:36 AM
P449: Selective depletion of LAG3+ cells in T-cell-driven inflammation: a randomised, double-blind, placebo-controlled, FTIH phase I/Ib clinical trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Ellis1, D. Marks*1, C. Barrett1, T. Hopkins1, A. Richards1, R. Fuhr2, M. Albayaty3, M. Coenen4, L. Liefaard5, K. Leavens1, K. Nevin1, S. Tang6, S. Hughes1, N. Srinivasan1, K. Edwards5, R. Anselm5, T. Schmidt7, J. Stone8, C. Savage1, N. Wisniacki1, R. Tarzi1

Created: Friday, 22 February 2019, 9:41 AM
P450 Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Biemans Drs1, E. Savelkoul2, G. Dijkstra3, M. Simsek4, R. Gabriels5, M. Pierik6, R. West7, N. de Boer8, F. Hoentjen2

Created: Thursday, 30 January 2020, 10:12 AM
P450: A gender comparison of the association between coping strategies and perceived social support in Crohn’s disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Sarid1, V. Slomin-Nevo1, D. Greenberg2, M. Friger3, D. Schwartz4, H. Vardi2, R. Sergienko3, E. Chernin3, S. Odes*5

Created: Friday, 22 February 2019, 9:49 AM
P450: Association of Infliximab trough levels and transmural healing in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Bernardo*1, S. Fernandes1, C. Simões1, A. R. Gonçalves1, C. Baldaia1, A. Valente1, P. Moura Santos1, L. Correia1, R. Marinho1

Created: Friday, 22 February 2019, 9:41 AM
P450: Mind the gap: Why do physicians underestimate their patient's adherence?
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Broide1,2*, A. Ein Dor1,3, A. B Shitrit4, N. Ruhimovich5, H. Shirin1,2, F.M. Konikoff3,5, T. Naftali3,5

Created: Thursday, 21 February 2019, 9:14 AM
P450: Real life Effectiveness and safety of an induction treatment with tofacitinib in patients with Ulcerative Colitis: First results of the French TOFAST cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fumery, M.(1)*;Bouhnik, Y.(2);Faure, P.(3);Bouzidi, A.(4);Brault, Y.(5);Peyrin-Biroulet, L.(6);Laharie, D.(7);
Created: Friday, 14 July 2023, 11:05 AM
P450: Reliability assessment of endoscopic scoring tools using central video review of colonoscopies in paediatric patients with ulcerative colitis: data from the Canadian Children IBD Network
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Carman N.*1, Huynh H.2, Walsh C.M.1, Ricciuto A.1, Mouzaki M.1, Crowley E.1, Church P.C.1, Walters T.D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P450: Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Livne- Margolin, M.(1);Ling, D.(1);Attia Konyo, S.(2);Haj, O.(1);Abitbol, C.M.(1);Ben-Horin, S.(1);Kopylov, U.(1);
Created: Friday, 11 February 2022, 3:52 PM
P450: Vaccination strategies in Inflammatory Bowel Disease patients: perspective of physicians and patients.
Year: 2021
Source: ECCO'21 Virtual
Authors: Ferreiro Iglesias, R.(1);Hernández Camba, A.(2);Saldaña, R.(3);Rodríguez-Lago, I.(4);Zabana, Y.(5);Barreiro-de Acosta, M.(6);
Created: Wednesday, 2 June 2021, 4:12 PM
P451 Short-and long-term effectiveness of ustekinumab in patients with Crohn’s disease: real-world data from a German IBD cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Kubesch1, L. Rueter1, K. Farrag2, T. Krause3, K. Stienecker4, J. Hausmann1, N. Filmann5, A. Dignass6, J. Stein2, I. Blumenstein1

Created: Thursday, 30 January 2020, 10:12 AM
P451: Compound IBD patient profiles are related to specific information needs – an Israeli national survey
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Daher S.*1, Benson A.1, Walker J.2, Hammerman O.1, Khoury T.1, Naftali T.3,4, Eliakim R.4,5, Ben-Bassat O.4,6, Bernstein C.2, Israeli E.1

Created: Wednesday, 20 February 2019, 10:36 AM
P451: Early infliximab trough levels in paediatric IBD patients predict sustained remission
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BeversMD, N.(1)*;Aliu, A.(2);Wong, D.(3);Derijks, L.(4);Winkens, B.(5);Vreugdenhil, A.(6);Pierik, M.(7);van Rheenen, P.(8);
Created: Friday, 14 July 2023, 11:05 AM
P451: Efficacy and safety of tofacitinib in the treatment of patients with active, moderate to severe, Ulcerative Colitis: a systematic review and meta-analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: KhorshidFASGE, M.(1);Dorgham, D.(2);Sharobim, A.(3);Attia, M.(4);Hussein, M.(5);Dorgham, N.(6);
Created: Wednesday, 2 June 2021, 4:12 PM